Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Informationsteknik |
| Industri | Programvara |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Aiforia Technologies Plc’s financial reporting and Annual General Meeting in 2026
Aiforia Technologies Plc, Company release, December 19, 2025 9:00 a.m. EET
Aiforia will publish the following financial reports and financial statements in 2026 as follows:
- March 6, 2026: Financial Statements Bulletin for financial year 2025
- March 11, 2026: The Financial Statements and the Board of Directors’ Report for financial year 2025
- August 28, 2026: Half-Year Financial Report for 1 January–30 June 2026
Aiforia Technologies’s Annual General Meeting is planned to be held on April 2, 2026. The Board of Directors will convene the meeting with a separate company release at a later date.
More information on the events of the financial year will be available on the company’s investor pages at https://investors.aiforia.com/investor-calendar.
Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358 405 009 878
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.
Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient.
Find out more at www.aiforia.com